A shadow market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Several professionals said the popularity for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, prosecution or prison.
Platform Response and Material Removal
Based on the social media company, the platform has removed problematic content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
After minutes of joining one community, a seller posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these groups, posts display black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious medical dangers”.
